CORRECTION article

Front. Cell. Neurosci., 07 January 2025

Sec. Cellular Neuropathology

Volume 18 - 2024 | https://doi.org/10.3389/fncel.2024.1546979

Corrigendum: Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation

  • 1. Faculty of Animal Science and Food Engineering, University of São Paulo (FZEA/USP), São Paulo, Brazil

  • 2. Institute of Biology, University of Campinas (IB/UNICAMP), Campinas, Brazil

  • 3. Institute of Biosciences, São Paulo State University, Rio Claro, Brazil

In the published article, there was an error in the Funding statement. In the Funding statement for the São Paulo Research Foundation, only grant 2021/09869–6 was displayed. The correct statement is São Paulo Research Foundation grant 2021/09869–6 and grant 2022/10604-0. The correct Funding statement appears below.

Statements

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This work was supported by São Paulo Research Foundation (FAPESP) under grant numbers 2021/09869-6 and 2022/10604-0, and by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES (Brazil) - funding code 001.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

extracellular vesicles, multiple sclerosis, neural stem cell, neurodegeneration, immunomodulation, oligodendrocyte precursor cell

Citation

Santos SIP, Ortiz-Peñuela SJ, de Paula Filho A, Tomiyama ALMR, Coser LO, da Silveira JC, Martins DS, Ciena AP, de Oliveira ALR and Ambrósio CE (2025) Corrigendum: Oligodendrocyte precursor cell-derived exosomes combined with cell therapy promote clinical recovery by immunomodulation and gliosis attenuation. Front. Cell. Neurosci. 18:1546979. doi: 10.3389/fncel.2024.1546979

Received

17 December 2024

Accepted

18 December 2024

Published

07 January 2025

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

18 - 2024

Updates

Copyright

*Correspondence: Sarah Ingrid Pinto Santos

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics